Randomized Clinical Trial
Copyright ©The Author(s) 2017.
World J Cardiol. Nov 26, 2017; 9(11): 807-812
Published online Nov 26, 2017. doi: 10.4330/wjc.v9.i11.807
Table 2 Procedural profiles of Safeguard Radial vs TR band groups
VariablesSafeguard radial, n = 42TR band, n = 42P value
Pre-procedure
IR verapamil, %(86%)(83%)0.77
IR nitroglycerine, %(31%)(45%)0.18
Procedural
Heparin, IU7778 ± 27047825 ± 24500.94
Number of target vessels treated with PCI
1
239391
≥ 3331
001
Target vessels
LM100.98
LAD/Diagonal19220.87
LCx/OM770.96
RCA18120.64
IM020.77
VG020.77
Fluoroscopy times, min15.3 ± 8.415.0 ± 6.90.88
Post-procedure
GP2B3A inhibitor, %1 (2%)0%0.32
ACT ( s )197 ± 38197 ± 470.97